Key Pharmacologic Principles and Drug-Drug Interactions in HIV Patient Care
Summary
- Efavirenz-based ART is the recommended option for patients receiving rifampin-based TB regimen
- Nevirapine-based or etravirine-based regimens should not be coadministered with rifampin due to the potential for significant decreases in NNRTI concentrations[DHHS ART]
- Rilpivirine and emtricitabine/rilpivirine/tenofovir DF, and emtricitabine/rilpivirine/tenofovir AF are contraindicated with rifampin[FDA Rilpivirine; FDA Emtricitabine/Rilpivirine/Tenofovir; FDA Emtricitabine/Rilpivirine/TAF]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content